Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H ( (HK:1858) ) has issued an update.
Beijing Chunlizhengda Medical Instruments Co., Ltd. has released its unaudited financial results for the three months ended 31 March 2026, prepared under PRC Accounting Standards for Business Enterprises. The first-quarter report, simultaneously published in Hong Kong and on the Shanghai Stock Exchange website, is available in both Chinese and English, with the Chinese version prevailing in case of discrepancies.
The board and senior management formally attest to the truthfulness, accuracy and completeness of the quarterly figures and accept joint and several legal responsibility for the disclosure. The company emphasizes that the report has not been audited and cautions shareholders and potential investors about the underlying investment risks associated with relying on the unaudited first-quarter data.
More about Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H
Beijing Chunlizhengda Medical Instruments Co., Ltd. is a mainland Chinese medical device manufacturer listed in Hong Kong and Shanghai, operating through a group structure focused on medical instruments. The company is governed by a board comprising executive, non-executive and independent non-executive directors, reflecting a typical listed-company governance framework.
Average Trading Volume: 723,413
Technical Sentiment Signal: Sell
Current Market Cap: HK$7.71B
For an in-depth examination of 1858 stock, go to TipRanks’ Overview page.